Ultrahuman has introduced the M2 Live, a new continuous glucose monitor designed to lower the cost of metabolic tracking. The company positions the device as a wellness tool rather than a medical instrument for insulin-dependent users. This launch replaces the brand's earlier 2021 model with a more compact sensor technology.
New wearable device offers flexible purchasing options for metabolic health monitoring
The M2 Live relies on Abbott's Lingo Sensor hardware to measure glucose levels in real time. Users wear the sensor for 14 days before discarding it and applying a fresh unit. The device syncs data to the Ultrahuman mobile application, which also displays metrics from the Ultrahuman Ring Air.
Specifications
- Sensor Type: Continuous Glucose Monitor (CGM)
- Sensor Manufacturer: Abbott (Lingo Sensor)
- Sensor Lifespan: 14 days
- Compatibility: Ultrahuman app, Ultrahuman Ring Air
- Subscription Price: $99 for two sensors per month
Ultrahuman offers flexible purchasing options for the M2 Live sensors to accommodate different usage patterns. The subscription plan costs 99 USD (around $99.00) per month and includes two sensors. Customers can also buy a two-pack for 129 USD (around $129) or an annual supply of 26 sensors for 1229 USD (around $1,229).
The companion application provides AI-driven insights to help users interpret their glucose trends. It combines the continuous glucose data with other health metrics collected by the wearable ring. This integration aims to give users a comprehensive view of their metabolic health.
The M2 Live will launch first in the U.S. market. This release marks the company's effort to make glucose tracking more affordable and accessible. The product completes the ecosystem of wearable health devices offered by the vendor.
Source: NotebookCheck
